Outcomes of a Pre-operative Exercise Programme for Live Donor and Recipient Kidney Transplant Patients
Launched by UNIVERSITY OF MANCHESTER · Feb 26, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether a special exercise program, combined with a smart device that you wear on your wrist or finger, can help kidney transplant donors and recipients prepare for surgery and improve their recovery afterward. The researchers want to find out if it’s easy for participants to join this program, if it leads to better health outcomes after surgery, and how the data from the wearable device relates to these outcomes. They will also look at how well participants sleep during this time and if that affects their recovery.
To be eligible for this trial, you need to be at least 18 years old and either a live kidney donor or a recipient of a kidney transplant. Unfortunately, if you have certain health issues, cannot wear the device, or do not speak English, you may not be able to participate. If you join, you’ll wear the device for 14 weeks, follow a 6-week exercise program at home or the gym, and keep a diary about your experiences. This study is not yet recruiting participants, but it aims to help improve the process of kidney transplants for both donors and recipients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 years and over
- • Live kidney donor or transplant recipient
- Exclusion Criteria:
- • Deceased donor transplant recipient
- • Patient unable to wear or tolerate wearable device
- • Unstable angina, recent myocardial infarction, recent cerebrovascular accident or new arrythmia
- • Patient declines or is unable to participate in the exercise programme
- • Lacks capacity to give informed consent to participate in trial
- • Non-English speaking
- • No access to a smart device to download application
About University Of Manchester
The University of Manchester is a leading research institution known for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university leverages its extensive expertise in biomedical research and clinical practice to develop and evaluate new therapies and interventions. The institution is dedicated to improving patient outcomes and public health by conducting rigorous, ethically sound trials that adhere to the highest standards of scientific integrity. Through its state-of-the-art facilities and a robust network of healthcare partnerships, the University of Manchester actively contributes to the global body of medical knowledge and the translation of research findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, , United Kingdom
Patients applied
Trial Officials
Gareth Kitchen
Principal Investigator
University of Manchester
Hussein Khambalia
Principal Investigator
Manchester University NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported